Chemo boosts survival rates for pancreatic cancer
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome. “This approval offers another treatment option for patients who suffer from these debilitating, severe seizures,” said Russell Katz, M.D., director of the Division of Neurology Products in the FDA’s
Full Post: FDA approves Banzel (rufinamide) for Lennox-Gastaut syndrome
The use of chemotherapy following surgery reduces the risk of death from operable pancreatic cancer by around 30 per cent, says new research published in the British Journal of Cancer.Pancreatic cancer is the tenth most common cancer. Nearly 7,600 people are diagnosed with the disease in the UK each year. But, survival rates remain a major concern - only around two or three per cent of patients survive for more than five years.
The new research, funded by Cancer Research UK, shows that patients who had surgery and chemotherapy with a drug called 5FU alongside folinic acid, had a five year survival rate of 24 per cent. This was compared to 14 per cent for those who only had surgery.
The researchers used the results of three clinical trials undertaken by The European Study Group for Pancreatic Cancer (ESPAC) to compare data of over 450 patients.
The study confirms the results of previous research which suggests patients who had surgery and chemotherapy had better a chance of survival than patients who only had surgery.
Professor John Neoptolemos, lead researcher based at the University of Liverpool, said: “Pancreatic cancer continues to be one of the hardest cancers to treat and has very low survival rates.
“These results show that chemotherapy after surgery is the best way to treat patients, giving people precious extra months or even years of life.
“There is still a long way to go before we can really reduce the number of people that die from the disease but this research moves us in the right direction. The next step will be to investigate different combinations of drugs to see if they work any better than this treatment.”
Kate Law, director of clinical trials at Cancer Research UK, said: “In the past it has been unclear what the best way to treat pancreatic cancer is. But, these results reinforce previous trial findings and show undoubtedly that chemotherapy after surgery offers the best hope for patients who have operable pancreatic cancer.
“Cancer Research UK recently launched a five year strategy to specifically target cancers with poor survival rates such as pancreatic cancer.
“Huge advancements have been made in beating cancer over the past thirty years. But progress has been faster in some areas than others. The strategy focuses our attention on those areas which will have the greatest impact on reducing cancer deaths in the future and on achieving our goals.”
Pancreatic cancer is one of the deadliest and most difficult to treat cancers. Now, in a major step forward, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have shown that administering radiation therapy prior to surgery nearly doubles survival in pancreatic cancer patients with operable tumors. “Patients who received pre-surgical (neoadjuvant) radiation had almost double the
Full Post: New study on pancreatic cancer survival
UC Davis Cancer Center researchers have discovered a metabolic deficiency in pancreatic cancer cells that can be used to slow the progress of the deadliest of all cancers. Published in the October issue of the International Journal of Cancer , study results indicate that pancreatic cancer cells cannot produce the amino acid arginine, which plays
Full Post: Researchers discover metabolic deficiency in pancreatic cancer
Survival for childhood bone cancer is slightly lower in the UK than in any other Western European country, according to research published in the British Journal of Cancer today (Wednesday). Although five-year survival from childhood cancer in the UK has now reached 75 per cent, and for some types of cancer survival is over 90
Full Post: UK survival for children’s bone cancer lowest in Western Europe
Reports from Taiwan say the sperm taken from a man with testicular cancer 13 years ago has been successfully used to impregnate his wife. The man was diagnosed with testicular cancer when he was 23, and sperm was taken and frozen before chemotherapy was used to treat the cancer as it was expected to render
Full Post: Twins born from 13-year-old frozen sperm
Online support communities for high survival rate cancers contain a greater amount of emotional support content than online support communities for cancers with low survival rates, according to a new study from the University of Michigan Health System and the VA Ann Arbor Healthcare System. The researchers also found that support communities for low survival
Full Post: Cancer survival rates impact type of Web communities used by patients